Research Frontiers (REFR) Stock Price, News & Analysis

Company Overview

Research Frontiers Incorporated engages in the development and marketing of technology and devices to control the flow of light worldwide. It develops and licenses suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, and electronics to power end-products incorporating the film, as well as lamination services for and the end-products, such as windows, skylights, and sunroofs. The company's SPD-Smart light-control technology is used in various product applications, including windows, sunshades, skylights, and interior partitions for homes and buildings; automotive windows, sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels, and navigation systems; aircraft windows; museum display panels, and eyewear products; and flat panel displays for electronic products. It serves architectural, automotive, marine, and aerospace and appliance applications. The company was incorporated in 1965 and is headquartered in Woodbury, New York.

Key Stats

• Today's Range: $1.49 to $1.62
• 50-Day Range: $1.49 to $2.05
• 52-Week Range: $0.93 to $2.39
• Volume: 49,882 shs
• Average Volume: 39,400 shs
• Market Capitalization: $51.29 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Research Frontiers Stock Analysis - MarketRank™

Research Frontiers scored higher than 2% of companies evaluated by MarketBeat, and ranked 651st out of 653 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Research Frontiers.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Research Frontiers is -51.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Research Frontiers is -51.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Research Frontiers has a P/B Ratio of 19.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.05% of the float of Research Frontiers has been sold short.

Short Interest Ratio / Days to Cover

Research Frontiers has a short interest ratio ("days to cover") of 7.9.

Change versus previous month

Short interest in Research Frontiers has recently decreased by 2.09%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Research Frontiers does not currently pay a dividend.

Dividend Growth

Research Frontiers does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.05% of the float of Research Frontiers has been sold short.

Short Interest Ratio / Days to Cover

Research Frontiers has a short interest ratio ("days to cover") of 7.9.

Change versus previous month

Short interest in Research Frontiers has recently decreased by 2.09%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.0 / 5
• News Sentiment: -0.29

News Sentiment

Research Frontiers has a news sentiment score of -0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Research Frontiers this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Research Frontiers insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 6.50% of the stock of Research Frontiers is held by insiders.

Percentage Held by Institutions

Only 11.91% of the stock of Research Frontiers is held by institutions.

REFR Stock Analysis - Frequently Asked Questions

How have REFR shares performed this year?

Research Frontiers' stock was trading at $1.71 at the beginning of the year. Since then, REFR stock has decreased by 10.5% and is now trading at $1.53.

How were Research Frontiers' earnings last quarter?

Research Frontiers Incorporated (NASDAQ:REFR) issued its quarterly earnings data on Thursday, March, 6th. The technology company reported ($0.02) earnings per share for the quarter. The technology company had revenue of $0.18 million for the quarter. Research Frontiers had a negative trailing twelve-month return on equity of 38.61% and a negative net margin of 66.16%.
Read the conference call transcript.

Who are Research Frontiers' major shareholders?

Top institutional shareholders of Research Frontiers include Kingsview Wealth Management LLC (0.47%). Insiders that own company stock include Alexander Kaganowicz and Darryl Daigle.
View institutional ownership trends.

How do I buy shares of Research Frontiers?

Shares of REFR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Research Frontiers own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Research Frontiers investors own include Energy Transfer (ET), Microvision (MVIS), Plug Power (PLUG), iBio (IBIO), NGL Energy Partners (NGL), Onconova Therapeutics (ONTX) and Blackstone (BX).

Company Calendar

• Last Earnings: 3/06/2025
• Today: 8/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: ELEC PRODS - MISC
• Sub-Industry: Trading
• Current Symbol: NASDAQ:REFR
• CIK: 793524
• Web: www.smartglass.com
• Phone: (516) 364-1902
• Fax: 516-364-3798
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.31 million
• Net Margins: -66.16%
• Pretax Margin: -66.10%
• Return on Equity: -38.61%
• Return on Assets: -29.51%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 11.95
• Quick Ratio: 11.95

Sales & Book Value

• Annual Sales: $1.34 million
• Price / Sales: 38.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.08 per share
• Price / Book: 19.13

Miscellaneous

• Outstanding Shares: 33,520,000
• Free Float: 31,339,000
• Market Cap: $51.29 million
• Optionable: Optionable
• Beta: 0.09